COVID-19: Epidemiology, Pathology, Diagnosis, Treatment, and Impact

被引:6
作者
Shahriar, Saimon [1 ]
Rana, Md. Sohel [1 ]
Hossain, Md. Sabbir [2 ]
Karim, Ariful [3 ]
Mredula, Tasneem N. [1 ]
Nourin, Nadia [1 ]
Uddin, Md. Sahab [3 ,4 ]
Amran, Md. Shah [1 ]
机构
[1] Univ Dhaka, Dept Pharmaceut Chem, Mol Pharmacol & Herbal Drug Res Lab, Dhaka 1000, Bangladesh
[2] Univ Dhaka, Dept Clin Pharm & Pharmacol, Dhaka 1000, Bangladesh
[3] Southeast Univ, Dept Pharm, Dhaka, Bangladesh
[4] Pharmakon Neurosci Res Network, Dhaka, Bangladesh
关键词
SARS-CoV-2; COVID-19; coronavirus; drug targets; second wave; mental health; CORONAVIRUS DISEASE 2019; SPIKE PROTEIN; CLINICAL CHARACTERISTICS; HEMAGGLUTININ-ESTERASE; FAVIPIRAVIR T-705; SARS CORONAVIRUS; CHINESE MEDICINE; MENTAL-HEALTH; CELL ENTRY; CHEST CT;
D O I
10.2174/1381612827666210224142446
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pandemic, well-known as COVID-19, has been caused by the coronavirus SARS-CoV-2 and it has distinct characteristics from other coronavirus-related epidemics. This pandemic has been ravaging the whole world for more than a year now, and no drugs or vaccines have been found to eliminate this virus from the infected people effectively; only physical measures like social distancing, hand washing and face-mask wearing have been taken to reduce its spread and very recently Veklury (remdesivir) has been permitted by the USFDA to manage the critical patients. This disease can be asymptomatic, but when it is symptomatic, it presents with respiratory problems and cold-or flu-like symptoms, which can be diagnosed with a chest CT and confirmed with RT-PCR tests. In this review, the taxonomy and structure of SARS-CoV-2 and history, transmission, epidemiology, pathology, clinical features and impacts of the COVID-19 have been discussed. A summary of possible drug targets, attempted physical and chemical measures, as well as vaccine candidates, has also been provided. How this coronavirus is different from other coronaviruses, the obstacles in managing this disease and the possibility of a second wave have also been reviewed. This review represents a wide range of information regarding COVID-19 and intends to be used as a comprehensive overview in this regard.
引用
收藏
页码:3502 / 3525
页数:24
相关论文
共 281 条
[51]   The spike glycoprotein of the new coronavirus 2019-nCoV contains a furinlike cleavage site absent in CoV of the same clade [J].
Coutard, B. ;
Valle, C. ;
de lamballerie, X. ;
Canard, B. ;
Seidah, N. G. ;
Decroly, E. .
ANTIVIRAL RESEARCH, 2020, 176
[52]   Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients [J].
da Silva, Juliana Cruz ;
Mariz, Henrique Ataide ;
da Rocha Junior, Laurindo Ferreira ;
Santana de Oliveira, Priscilla Stela ;
Dantas, Andrea Tavares ;
Branco Pinto Duarte, Angela Luzia ;
Pitta, Ivan da Rocha ;
Galdino, Suely Lins ;
da Rocha Pitta, Maira Galdino .
CLINICS, 2013, 68 (06) :766-771
[53]   The Pathophysiology, Diagnosis and Treatment of Corona Virus Disease 2019 (COVID-19) [J].
Das, Subir Kumar .
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2020, 35 (04) :385-396
[54]   Coronavirus disease 2019 (COVID-19) pandemic and pregnancy [J].
Dashraath, Pradip ;
Wong, Jing Lin Jeslyn ;
Lim, Mei Xian Karen ;
Lim, Li Mm ;
Li, Sarah ;
Biswas, Arijit ;
Choolani, Mahesh ;
Mattar, Citra ;
Su, Lin Lin .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (06) :521-531
[55]  
De Clercq Erik, 2006, Expert Rev Anti Infect Ther, V4, P291, DOI 10.1586/14787210.4.2.291
[56]   New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections [J].
De Clercq, Erik .
CHEMISTRY-AN ASIAN JOURNAL, 2019, 14 (22) :3962-3968
[57]   Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV [J].
De Clercq, Erik .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 (04) :307-320
[58]   PIKfyve Regulation of Endosome-Linked Pathways [J].
de Lartigue, Jane ;
Polson, Hannah ;
Feldman, Morri ;
Shokat, Kevan ;
Tooze, Sharon A. ;
Urbe, Sylvie ;
Clague, Michael J. .
TRAFFIC, 2009, 10 (07) :883-893
[59]   Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening [J].
de Oliveira, Osmair Vital ;
Rocha, Gerd B. ;
Paluch, Andrew S. ;
Costa, Luciano T. .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (11) :3924-3933
[60]   SARS-CoV-2 was already spreading in France in late December 2019 [J].
Deslandes, A. ;
Berti, V ;
Tandjaoui-Lambotte, Y. ;
Alloui, Chakib ;
Carbonnelle, E. ;
Zahar, J. R. ;
Brichler, S. ;
Cohen, Yves .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (06)